|
CAS-Nr. | 401-10-5 |
Bezeichnung: | |
Englisch Name: | E-Retinoylb-glucuronide |
Synonyma: | retinoyl glucuronide;E-Retinoylb-glucuronide;Retinoyl-β-D-glucuronide;Retinoyl beta-glucuronide;(E-Retinoyl)-β-glucuronide;13-cis-Retinoyl glucuronide;E-Retinoyl β-glucuronide ,85%;Retinoyl-β-D-glucuronopyranoside;Retinoyl β-D-glucuronopyranoside;Retinoic acid beta-D-glucuronide |
CBNumber: | CB51231897 |
Summenformel: | C26H36O8 |
Molgewicht: | 476.562 |
MOL-Datei: | 401-10-5.mol |
|
|
|
|
E-Retinoylb-glucuronide physikalisch-chemischer Eigenschaften |
storage temp. : |
Amber Vial, -20°C Freezer, Under Inert Atmosphere |
|
|
E-Retinoylb-glucuronide Chemische Eigenschaften,Einsatz,Produktion Methoden |
Chemische Eigenschaften Yellow Solid |
|
Verwenden A biliary metabolite of Vitamin A, occurs endogenously in human blood. RAG is biologically active in promoting the growth of vitamin A-deficient rats and the the induction of differentiation of HL-60 and BA-HAN-1C cells, but less cytotoxic than Retinoic Acids. |
|
|
E-Retinoylb-glucuronide Upstream-Materialien And Downstream Produkte |
Upstream-Materialien
|
Downstream Produkte
|
E-Retinoylb-glucuronide Anbieter Lieferant Produzent Hersteller Vertrieb Händler. Global( 5)Lieferanten |
|
|
|
|
401-10-5
E-Retinoylb-glucuronide
(2S,3S,4S,5R,6S)-6-[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenoyl]oxy-3,4,5-trihydroxy-oxane-2-carboxylic acid
Retinoyl beta-glucuronide
retinoyl glucuronide
[(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-1-oxo-2,4,6,8-nonatetrenyl]β-D-glucopyranosiduronic acid
Retinoyl β-D-glucopyranosiduronic acid
Retinoyl β-D-glucuronopyranoside
Retinoyl-β-D-glucuronide
Retinoyl-β-D-glucuronopyranoside
13-cis-Retinoyl glucuronide
9-cis-Retinoyl-beta-D-glucuronide
beta-D-Glucopyranuronic acid, 1-ester with retinoic acid
beta-D-Glucopyranuronic acid, 1-retinoate
Retinoic acid beta-D-glucuronide
E-Retinoyl β-glucuronide ,85%
Glucuronides
Metabolites
Retinoids
(E-Retinoyl)-β-glucuronide
|